The Leukemia & Lymphoma Society of Canada was honoured to be invited to speak at the Canadian Association of Pharmacy in Oncology (CAPhO) in Moncton, New Brunswick this month.
Christina Sit, Manager of Strategic Community Partnership, LLSC, presented on the role of pharmacists in supporting access to novel cancer treatments, in tandem with a leading pharmacist about one such novel treatment for a blood cancer.
Rami El-Sharkaway, Clinical Pharmacist, Complex Malignant Hematology, Stem Cell Transplant & Cellular Therapy Program, Juravinski Hospital and Cancer Centre in Hamilton, Ontario, presented on the role of pharmacists in managing bispecific antibody-related, immune-mediated adverse events in relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
Nadine Prevost, Director, Research & Community Services, LLSC, was the moderator of the co-presentation. The room at the CAPhO hybrid session was full, with many more attendees online.
